A vulnerability has been found in Hospira Plum A+ Infusion System, Plum A+3 Infusion System and Symbiq Infusion System (Medical Device Software) (affected version not known) and classified as critical. Affected by this vulnerability is some unknown functionality. The manipulation with an unknown input leads to a information disclosure vulnerability. The CWE definition for the vulnerability is CWE-200. The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information. As an impact it is known to affect confidentiality, integrity, and availability. The summary by CVE is:

Wireless keys are stored in plain text on Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.

The weakness was shared 03/25/2019. This vulnerability is known as CVE-2015-3952 since 05/12/2015. The exploitation appears to be easy. The attack can be launched remotely. The exploitation doesn't need any form of authentication. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1592 for this issue.

There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.

The entries 132172, 132171 and 132170 are related to this item.

Productinfo

Type

• Medical Device Software

Vendor

• Hospira

Name

• Plum A+3 Infusion System
• Plum A+ Infusion System
• Symbiq Infusion System

CVSSv4info

CVSSv3info

CVSSv2info

Exploitinginfo

Threat Intelligenceinfo

Countermeasuresinfo

Timelineinfo

Sourcesinfo

Entryinfo

Discussion